Vixen Bio
Private Company
Funding information not available
Overview
Vixen Bio is a specialized Contract Research Organization (CRO) based in Leuven, Belgium, offering tailored bioanalytical services centered on antibody characterization and immune response analysis. Leveraging its proprietary FO-SPR sensor technology, the company provides rapid, custom assay development and sample analysis for a wide range of biological entities, from purified proteins to complex clinical samples. Its core value proposition is de-risking preclinical and clinical development for biopharma clients by delivering real-time, clinically relevant data. While operating as a service and supplies business, Vixen Bio positions itself as an innovation partner in the precision medicine ecosystem.
Technology Platform
Proprietary Fiber-Optic Surface Plasmon Resonance (FO-SPR) biosensor technology (WHITE FOx) enabling real-time, label-free analysis of biomolecular interactions in complex biological samples.
Opportunities
Risk Factors
Competitive Landscape
Vixen Bio competes with large, full-service CROs (e.g., LabCorp, IQVIA, Charles River) that have bioanalytical divisions, as well as specialized boutique CROs focusing on immunology or biologics. Its technology also competes with other label-free detection platforms (e.g., Biacore SPR, Octet BLI) from established life science tools companies. Differentiation is based on speed, customization, and expertise in complex sample matrices.